Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

After an FDA warning, Medtronic has recalled two of its MiniMed insulin pump products that could be wirelessly interfered with by hackers. Medtronic thinks there’s no evidence that anyone using ...

Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success ...

WASHINGTON, D.C. — The U.S. Food and Drug Administration has issued a Class I recall, the most serious type, on Medtronic’s ...

Medtronic (NYSE:MDT) issued an urgent field safety notice in Europe related to multiple versions of its MiniMed insulin pump ...

The U.S. Food and Drug Administration has approved Medtronic's MiniMed Paradigm insulin pump, which is also a glucose monitor. The U.S. Food and Drug Administration has approved Medtronic's ...

Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes.

Shares of Medtronic (NYSE: MDT ... And in the highly competitive diabetes care segment, the new MiniMed 780G insulin pump system employs AI algorithms to predict and automatically adjust insulin ...

Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

George Alternatively, to learn more about insulin pump therapy please visit medtronic-diabetes.co.uk. Speak to your Healthcare Professional (HCP) for more information. At no point should this be seen ...

After an FDA warning, Medtronic has recalled two of its MiniMed insulin pump products that could be wirelessly interfered with by hackers. Medtronic thinks there’s no evidence that anyone using ...